Fig. 1
From: Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients
Predictive individual causal association by the best model according to the number of predictors: 1-proportion of CD4+ T cell, 2- proportion of CD4+ T cell and absolute monocytes counts, 3- proportion of CD4+ T cell, NLR and Neutrophils, 4- proportion of CD4+ T cell, NLR, Neutrophils and Eosinophils, 5- Proportion of CD4+ T cell, basal EGF concentration, NLR, Monocytes and Neutrophils, 6- Proportion of CD4+ T cell, Proportion of CD8+ T cell, basal EGF concentration, NLR, Monocytes and Neutrophils, 7- Proportion of CD4+ T cell, Proportion of CD8+ T cell, basal EGF concentration, NLR, Monocytes, Neutrophils and Eosinophils